Susvimo has the same active ingredient as Roche's big-selling therapy Lucentis (ranibizumab), a VEGF inhibitor administered once a month that has been approved by the FDA since 2006 for wet AMD.

The renaissance of Roche's refillable ophthalmic implant Susvimo has continued with FDA approval for use in patients with diabetic macular oedema.

Roche has secured its third antibody-drug conjugate pact of the year, this time agreeing to hand $36 million in upfront payments to Oxford BioTherapeutics. The agreement will also see U.K.-based ...

Two months after U.S. President Donald Trump issued an executive order proclaiming diversity, equity and inclusion (DEI) programs “illegal and immoral,” Roche has scrapped its high-profile ...

The moment every 1923 fan has been waiting for has finally arrived. In this week’s episode, Father Renaud (Sebastian Roché) finally catches up with Teonna Rainwater (Aminah Nieves). After ...

ZURICH, March 19 (Reuters) - Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the latest companies ...

The actor who plays a villain on the ‘Yellowstone’ prequel series explains how his character’s “diabolical” mission led to a “dissent into madness” for the man who would never die ...

The recall affects acne creams from well-known retailers such as Walgreens, La Roche-Posay, and Proactiv. The U.S. Food and Drug Administration (FDA) issued a recall notice on March 11th ...

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of March 2025. The chart below provides highlights of key monograph updates ...

Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) Meningococcal vaccine For active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y in ...

Global drugmakers' stocks dropped across the board after U.S. President Donald Trump reiterated plans for a "major" tariff on pharmaceutical imports, threatening an interwoven global supply chain ...

The following table presents notable drug approvals of February 2025. Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) Meningococcal vaccine For active immunization to prevent invasive ...